Revvity, Inc. (RVTY)

Market Cap	11.37B
Revenue (ttm)	2.77B
Net Income (ttm)	286.61M
Shares Out	120.15M
EPS (ttm)	2.35
PE Ratio	40.28
Forward PE	18.64
Dividend	$0.28 (0.30%)
Ex-Dividend Date	Jul 18, 2025

Volume	1,772,906
Open	94.92
Previous Close	95.06
Day's Range	93.47 - 96.21
52-Week Range	89.36 - 129.50
Beta	1.07
Analysts	Buy
Price Target	127.00 (+34.16%)
Earnings Date	Apr 28, 2025

About RVTY

Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company’s Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for tes...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1937
• Employees: 11,000
• Stock Exchange: NYSE
• Ticker Symbol: RVTY
• Website: https://www.revvity.com

Financial Performance

In 2024, Revvity's revenue was $2.76 billion, an increase of 0.16% compared to the previous year's $2.75 billion. Earnings were $270.39 million, a decrease of -60.99%.

Analyst Forecast

According to 12 analysts, the average rating for RVTY stock is "Buy." The 12-month stock price forecast is $127.0, which is an increase of 34.16% from the latest price.

Price Target

$127.0

(34.16% upside)

Analyst Consensus: Buy